PetMed Express
Stock Forecast, Prediction & Price Target

PetMed Express Financial Estimates

PetMed Express Revenue Estimates

PetMed Express EBITDA Estimates

PetMed Express Earnings per Share Estimates

Passed Analyst forecast
Metric 3/31/2022 3/31/2023 3/31/2024 3/31/2026 3/31/2027
Revenue
 
% change YoY
$273.41M
 
N/A
$256.85M
 
-6.05%
$281.06M
 
9.42%
Avg: $293.36M
Low: $289.50M
High: $297.22M
avg. 4.37%
Avg: $312.00M
Low: $307.89M
High: $316.11M
avg. 6.35%
Net Income
 
% change YoY
$18.71M
 
N/A
$233K
 
-98.75%
$-7.46M
 
-3303.43%
Avg: $-1.98M
Low: $-2.44M
High: $-1.42M
avg. 73.39%
Avg: $-2.17M
Low: $-2.07M
High: $-2.00M
avg. -9.39%
EBITDA
 
% change YoY
$28.44M
 
N/A
$2.11M
 
-92.56%
$-1.10M
 
-152.26%
Avg: $21.06M
Low: $20.78M
High: $21.34M
avg. 2004.44%
Avg: $22.40M
Low: $22.10M
High: $22.69M
avg. 6.35%
EPS
 
% change YoY
$1.05
 
N/A
$0.01
 
-98.90%
-$0.37
 
-3317.39%
Avg: -$0.1
Low: -$0.12
High: -$0.07
avg. 74.32%
Avg: -$0.1
Low: -$0.1
High: -$0.1
avg. -5.26%
Operating Expenses
 
% change YoY
$52.36M
 
N/A
$72.44M
 
38.34%
$86.81M
 
19.83%
Avg: $62.17M
Low: $61.35M
High: $62.99M
avg. -28.37%
Avg: $66.12M
Low: $65.25M
High: $66.99M
avg. 6.35%

FAQ

What is PetMed Express stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 31.99% in 2026-2027.

We have gathered data from 1 analysts. Their low estimate is -2.44M, average is -1.98M and high is -1.42M.

What is PetMed Express stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 5.36% in 2026-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $289.50M, average is $293.36M and high is $297.22M.

What is PetMed Express stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 34.53% in 2026-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.12, average is -$0.1 and high is $-0.07.

What is the best performing analyst?

In the last twelve months analysts have been covering PetMed Express stock. The most successful analyst is Ryan Meyers.